SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score
SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers.
Browse SUDOSCAN’s main peer-reviewed publications by application, from technology validation to clinical use across therapeutic areas.
Stay updated on recent SUDOSCAN research, clinical evidence, and advances in sudomotor function assessment worldwide.
Submit your clinical research proposal involving SUDOSCAN or EZSCAN technology for review by Impeto Medical’s research team.
Sign up to receive the latest SUDOSCAN scientific news, publications, and clinical research updates by email.
An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.
Simple results obtained in 3 minutes.